NCT04568226Completed
The Effect of Metacognition-based, Manualized Intervention on Fear of Cancer Recurrence
The Effect of Metacognition-based, Manualized Intervention on Fear of Cancer Recurrence: a Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 18 Jun 2024
Brief summary (registry, in English)
The primary aim of this study is to assess the effect of ConquerFear, a metacognition-based manualized intervention on fear of cancer recurrence, using the randomized controlled trial approach, among Chinese patients newly diagnosed with curable cancer. This study aims to (1) test the direct effect of ConquerFear intervention on fear of cancer recurrence and on maladaptive metacognition, and (2) to test the indirect effect of ConquerFear intervention on fear of cancer recurrence through its effect on maladaptive metacognition.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 177 (actual)
- First submitted
- 22 Sept 2020
- Start date
- 21 Jul 2021
- Primary completion date
- 30 Sept 2023
- Lead sponsor
- The University of Hong Kong
- Diseases
- Colorectal cancer
- NCT number
- NCT04568226
What you commit to
- Study type: Interventional
- Participants enrolled: 177
- From 21 Jul 2021 to the primary completion date, 30 Sept 2023
- 6 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- currently receiving psychological treatment
Other illness
- Patients diagnosed with metastatic cancer
Other
- non-Chinese ethnicity
- with a current diagnosis of depression or psychosis
- with language difficulties or intellectual disability.
Who the study is looking for
- Cantonese- or Mandarin-speaking Chinese patients recently diagnosed with non-metastatic breast cancer, gynecologic cancer, or colorectal cancer
- had surgery as a primary treatment
- have had completed hospital-based adjuvant treatments including radiotherapy and chemotherapy within the past 18 months
- with the cut-off scored ≥ 13 on Severity, the subscale of Fear of cancer inventory
- are able to read and write Chinese
- are over the age of 18 years
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (6)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Prince of Wales Hospital-Department of Surgery Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Unknown status |
| Tung Wah Hospital-Department of Surgery Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Unknown status |
| Kwong Wah Hospital-Breast Center Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Unknown status |
| The University of Hong Kong Jockey Club Institute of Cancer Care Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Unknown status |
| Queen Mary Hospital-Department of Obstetrics & Gynaecology Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Unknown status |
| Queen Mary Hospital-Department of Surgery Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.